Personalis

IPO

Transforming the Active Management of Cancer

Public · Menlo Park, United States · Founded 2011 · $33.0M raised

Employees
201–500
Founded
2011
Business Model
B2B
Total Funding
$33.0M
Last Round
$33.0M Series CJan 2015
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biopharma, now publicly traded (NASDAQ: PSNL).

Summary

Personalis is a Genomics company based in Menlo Park, United States, founded in 2011. It has raised $33.0M in total across 1 round, most recently a $33.0M Series C round in Jan 2015. Investors include Lightspeed Venture Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2019
$115.0M

Sign up to see all 2 events

Funding: Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Personalis on Indexed.vc
<a href="https://indexed.vc/companies/personalis"><img src="https://indexed.vc/api/badge/company/personalis" alt="Personalis on Indexed.vc" width="260" height="76" /></a>